ESR1 and breast carcinoma: In this study, we observed that, in breast cancer cell lines and clinical tumor specimens, δEF1 was expressed at a higher level in ER- cells compared to ER+ cells, indicating that δEF1 might contribute to the malignant conversion of breast cancer cells towards invasive and metastatic phenotypes.